THE ONLY PROVIDER OF SCIENTIFICALLY VALID PATIENT CHART AUDIT / TREATING PHYSICIAN RESEARCH

​​Pulmonology / infectious disease

© 2014-2017 Clarity Pharma Research LLC  |  All Rights Reserved​ Privacy Policy
To learn more about our services, call (864) 208-0078 or contact information@claritypharma.com.
S
ubscribe to our newsletter at: http://eepurl.com/ovQcb

Nontuberculous mycobacteria pulmonary disease  A variety of strains cause this rare infectious lung disease. We have conducted 7-nation market sizing studies and have compared treatment patterns for NTMPD in the US, Europe, and Asia.


We captured detailed information about current treatment practices, patient characteristics and disease states, and other medications used as therapy, with the goal of helping the client to see where its product might fill gaps. We also have studied refractory populations and the burden of illness in several nations.


Findings on some of this research have been published in medical journals and at international medical conferences, as shown in the "Related Articles or Presentations" column on this page


​We also have studied other lung conditions, including chronic obstructive pulmonary disease (COPD), asthma and forms of lung cancer.

Related Articles or Presentations

  • ISPOR conference, retrospective observational study to capture economic burden evidence in a rare disease AbstractPoster
  • EphMRA, “Precedent and consequence research to undergird orphan reimbursement strategy – A multi-layered, non-traditional approach” Presentation
  • Japanese Respiratory Society, treatment patterns for a rare lung disease in EU5, Japan and US Abstract
  • European Respiratory Society, prevalence and incidence of a rare lung disease in Europe Abstract
  • European Respiratory Society, treatment patterns for rare disease in EU5, Japan and US Abstract
  • European Respiratory Journal, treatment patterns for a rare lung infection in Europe, US and Japan, and article on prevalence in Europe, co-written with international team of medical experts,  Abstract 1& 2
  • KIT 2014 (Congress for Infectious Diseases and Tropical Medicine), co-author, rare lung infection prevalence in Germany Abstract
  • Annals of the American Thoracic Society, US study of rare lung infection Abstract  
  • American Thoracic Society (ATS) International Conference, study of rare lung infection Abstract